MARKET

ICU

ICU

SeaStar Medical Holding Corp
NASDAQ
2.340
-0.020
-0.85%
After Hours: 2.310 -0.03 -1.28% 19:03 02/11 EST
OPEN
2.370
PREV CLOSE
2.360
HIGH
2.420
LOW
2.250
VOLUME
59.19K
TURNOVER
--
52 WEEK HIGH
25.70
52 WEEK LOW
2.200
MARKET CAP
8.89M
P/E (TTM)
-0.1425
1D
5D
1M
3M
1Y
5Y
1D
SeaStar Medical reports ‘strong’ survival data in Quelimmune study
TipRanks · 2d ago
SeaStar Medical Publishes Data On Early Post-Approval Clinical Experience From Use Of QUELIMMUNE Device For Pediatrics Therapy
Benzinga · 2d ago
SeaStar Medical Reports Strong Real-World Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury
Reuters · 2d ago
Weekly Report: what happened at ICU last week (0202-0206)?
Weekly Report · 2d ago
SeaStar Medical Announces Publication in Pediatric Nephrology of Positive Real-World Experience for QUELIMMUNE™ (SCD-PED) Therapy in Pediatric Acute Kidney Injury (AKI)
Barchart · 2d ago
Weekly Report: what happened at ICU last week (0126-0130)?
Weekly Report · 02/02 10:04
SeaStar Medical to Present at Noble Capital Markets Emerging Growth Virtual Equity Conference
Reuters · 01/29 13:25
Weekly Report: what happened at ICU last week (0119-0123)?
Weekly Report · 01/26 10:04
More
About ICU
SeaStar Medical Holding Corporation is a commercial-stage medical technology company, which is focused on transforming treatments for critically ill patients facing organ failure and potential loss of life. The Company’s Selective Cytopheretic Device (SCD) is designed as a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation and creates a cascade of events that wreak havoc in the patient’s body. It has broad potential applications for patients suffering from both acute and chronic kidney disease as well as cardiovascular and other serious inflammatory diseases. Its SCD therapy is an extracorporeal synthetic membrane device designed to bind activated leukocytes (neutrophils and monocytes) when integrated into an existing continuous renal replacement therapy (CRRT) circuit in conjunction with the use of regional citrate anticoagulation (RCA).

Webull offers SeaStar Medical Holding Corp stock information, including NASDAQ: ICU real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ICU stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ICU stock methods without spending real money on the virtual paper trading platform.